Immunotherapy of Advanced Colorectal Cancer By Enlisting Bystander T Cells – Cancer Therapy Advisor
Cancer Therapy Advisor |
Immunotherapy of Advanced Colorectal Cancer By Enlisting Bystander T Cells
Cancer Therapy Advisor The immune checkpoint inhibitors, which include antagonist antibodies against PD-1, PD-L1, or CTLA-4, demonstrate activity against a broad range of tumors, but produce only minimal activity in advanced colorectal cancer (CRC), except for the subset … |
